Abstract
We report a case of fatal HBV reactivation in a patient with chronic hepatitis B infection HBeAg-, who was withdrawn from antiviral therapy.. We think that it may be a warning of risks that this clinical decision may entail.
MeSH terms
-
Antiviral Agents* / adverse effects
-
Antiviral Agents* / therapeutic use
-
Fatal Outcome
-
Hepatitis B, Chronic* / complications
-
Hepatitis B, Chronic* / drug therapy
-
Humans
-
Liver Failure* / etiology
-
Male
-
Middle Aged
-
Withholding Treatment